Somite AI
United States
- Boston, Massachusetts
- 14/05/2025
- Series A
- Undisclosed Amount
Somite.ai is developing AI foundation models for human stem cells to drive novel cell therapies at scale. We take a full-stack approach—generating data at 1,000x lower cost, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy.
Our founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT (pioneered the foundational research on scaling laws), and four Harvard Medical School professors and National Academy of Sciences/Medicine members, including the Chair of the Genetics Department at HMS. Based in Boston and launching operations in January 2024, Somite has raised over $11M in pre-seed funding
- Industry Biotechnology Research
- Website https://www.somite.ai/
- LinkedIn https://www.linkedin.com/company/somite-therapeutics/
Related People
Micha Y. Breakstone 🇮🇱🎗️Co Founder
United States -
Austin, Texas
I’m a repeat entrepreneur who’s founded a few great businesses (e.g. chorus.ai), and am on a journey to make the world a slightly better place, one company at a time.
Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Arya Health | $18,200,000 | (Oct 30, 2025)
iPNOTE - Your Virtual IP Paralegal | $1,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)